These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38493452)

  • 21. Assessment of neutrophil and neutrophil/lymphocyte ratio in coronary collateral developed patients with acute coronary syndrome.
    Mansiroglu AK; Sincer I; Gunes Y
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):954-959. PubMed ID: 32844936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-to-Lymphocyte Ratio at Admission as a Predictor of In-Hospital and Long-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Willim HA; Harianto JC; Cipta H
    Cardiol Res; 2021 Apr; 12(2):109-116. PubMed ID: 33738014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome.
    Zengin A; Karaca M; Aruğaslan E; Yıldırım E; Karataş MB; Çanga Y; Emre A; Tayyareci G
    J Cardiovasc Thorac Res; 2021; 13(2):125-130. PubMed ID: 34326966
    [No Abstract]   [Full Text] [Related]  

  • 25. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Verdoia M; Nardin M; Gioscia R; Negro F; Marcolongo M; Suryapranata H; Kedhi E; De Luca G;
    Vascul Pharmacol; 2020 Sep; 132():106765. PubMed ID: 32681888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction.
    Yoon GS; Choi SH; Woo SI; Baek YS; Park SD; Shin SH; Kim DH; Kwan J; Lee MJ; Kwon SW
    J Korean Med Sci; 2021 May; 36(19):e131. PubMed ID: 34002551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome.
    Sheng J; Liu N; He F; Cheng C; Shen S; Sun Y
    Clinics (Sao Paulo); 2021; 76():e2580. PubMed ID: 34378727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
    Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
    Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
    Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
    Chiarito M; Cao D; Cannata F; Godino C; Lodigiani C; Ferrante G; Lopes RD; Alexander JH; Reimers B; Condorelli G; Stefanini GG
    JAMA Cardiol; 2018 Mar; 3(3):234-241. PubMed ID: 29417147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of the Neutrophil-to-Lymphocyte Ratio on In-Hospital Outcomes in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Karaca G; Ekmekci A; Kimiaei A; Safaei S; Özer N; Tayyareci G
    Cureus; 2024 Feb; 16(2):e54418. PubMed ID: 38375058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of myocardial salvage index by cardiac magnetic resonance in ST-segment elevation myocardial infarction patients: a systematic review and meta-analysis.
    Xiao Z; Zhong J; Zhong L; Dai S; Lu W; Song L; Zhang H; Yang J; Yao W
    Eur Radiol; 2023 Nov; 33(11):8214-8225. PubMed ID: 37328640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.